Hi Danny,
I think I misunderstood your original question, so I apologise for suggesting you hadn't done research. I agree with everything you say except, the milestone payment from Roche with progression to stage two which, I think will be double your estimate of $2-3 Million. I reckon $4-6 million given the number of infections that the targeted bacteria causes. Guess we'll just have to wait and see whose right! I did get the impression from Nick Woolf that Roche are very positive how the testing has gone and the decision is close.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15857 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |